Context Therapeutics Context Therapeutics is a clinical-stage biopharmaceutical company dedicated to creating medicines treating hormone-responsive cancers. | ![]() Sunesis Pharmaceuticals Sunesis Pharmaceuticals is focused on the R&D of oncology therapeutics for the treatment of solid and hematologic cancers. | ||
Founding Date | Founding Date 2015 | Founding Date 1987 | Founding Date 2015 |
Type | Type Public | Type Subsidiary | Type Public |
Tags | |||
Locations | Locations Philadelphia, US HQ Philadelphia, US | Locations South San Francisco, US HQ | Locations South San Francisco, US HQ San Diego, US |
Employees | Employees 2 | Employees 42 | Employees 56 |
Valuation ($) | Valuation ($) 168 m | Valuation ($) N/A | Valuation ($) 2.5 b |
Financial | |||
Net income | Net income ($36.1m) (FY, 2025) | Net income ($114.8m) (FY, 2021) | Net income ($113.7m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 171.7m | Total funding raised $ 140m |

Sunesis Pharmaceuticals is focused on the R&D of oncology therapeutics for the treatment of solid and hematologic cancers.
View company
IDEAYA Biosciences (IDEAYA) is a developer of molecular therapies.
View company